Georg Bernhard Landwehrmeyer MD, FRCP

Dr. Landwehrmeyer has been a Full Professor of Neurology ‘Clinical Neurobiology,’ University of Ulm, Ulm, Germany, since 2000. He is one of the founders of the European HD Network (EHDN), served for the first ten years since the constitution of EHDN as Chairman of the EHDN’s Executive Committee and continues to serve as a leader of the EHDN project at Ulm University. Since 2011 Dr. Landwehrmeyer is the Principal Investigator of Enroll-HD, a worldwide, prospective, observational Huntington disease (HD) cohort study for HD families, sponsored by CHDI Foundation, USA. Dr. Landwehrmeyer directs the HD center at Ulm, a multi-disciplinary center providing genetic counseling, clinical in- and out-patient services as well as rehabilitation for HD affected families along with basic and translational science.

Dr. Landwehrmeyer received his medical degree from the the Albert Ludwig University of Freiburg in Germany, where he also completed a residency in neurology, research training in neuropathology and molecular pharmacology, and a residency in neurology and psychiatry. Additional postgraduate training included studies at the Kantonsspital in Basel, Switzerland, and a research fellowship at the Massachusetts General Hospital, Harvard Medical School in Boston, Mass., USA.